Current management of venous ulcers: an evidence-based review.

Jordana Herschthal, Robert Kirsner

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Chronic venous ulceration is a common and important medical problem that causes significant morbidity. Venous ulcers are expensive to treat, have substantial economic effects in terms of days of work lost, and adversely impact the patient's quality of life. Relying on evidence allows for a rationale of clinical decision making. The objectives of venous ulcer management include the healing of the ulcer, prevention of recurrence, and improvement of edema. Compression is the cornerstone of venous ulcer therapy. Adjunctive modalities such as surgery, growth factors, grafting, biologic skin substitutes, dressings, and oral medication have differing levels of evidence supporting their use, and may also facilitate the healing process.

Original languageEnglish
Pages (from-to)77-83
Number of pages7
JournalSurgical technology international
Volume17
StatePublished - Dec 1 2008

Fingerprint

Varicose Ulcer
Artificial Skin
Bandages
Ulcer
Edema
Intercellular Signaling Peptides and Proteins
Economics
Quality of Life
Morbidity
Recurrence
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Current management of venous ulcers : an evidence-based review. / Herschthal, Jordana; Kirsner, Robert.

In: Surgical technology international, Vol. 17, 01.12.2008, p. 77-83.

Research output: Contribution to journalArticle

@article{acdae293c82147b8b68042ce7c981ec9,
title = "Current management of venous ulcers: an evidence-based review.",
abstract = "Chronic venous ulceration is a common and important medical problem that causes significant morbidity. Venous ulcers are expensive to treat, have substantial economic effects in terms of days of work lost, and adversely impact the patient's quality of life. Relying on evidence allows for a rationale of clinical decision making. The objectives of venous ulcer management include the healing of the ulcer, prevention of recurrence, and improvement of edema. Compression is the cornerstone of venous ulcer therapy. Adjunctive modalities such as surgery, growth factors, grafting, biologic skin substitutes, dressings, and oral medication have differing levels of evidence supporting their use, and may also facilitate the healing process.",
author = "Jordana Herschthal and Robert Kirsner",
year = "2008",
month = "12",
day = "1",
language = "English",
volume = "17",
pages = "77--83",
journal = "Surgical technology international",
issn = "1090-3941",
publisher = "Universal Medical Press",

}

TY - JOUR

T1 - Current management of venous ulcers

T2 - an evidence-based review.

AU - Herschthal, Jordana

AU - Kirsner, Robert

PY - 2008/12/1

Y1 - 2008/12/1

N2 - Chronic venous ulceration is a common and important medical problem that causes significant morbidity. Venous ulcers are expensive to treat, have substantial economic effects in terms of days of work lost, and adversely impact the patient's quality of life. Relying on evidence allows for a rationale of clinical decision making. The objectives of venous ulcer management include the healing of the ulcer, prevention of recurrence, and improvement of edema. Compression is the cornerstone of venous ulcer therapy. Adjunctive modalities such as surgery, growth factors, grafting, biologic skin substitutes, dressings, and oral medication have differing levels of evidence supporting their use, and may also facilitate the healing process.

AB - Chronic venous ulceration is a common and important medical problem that causes significant morbidity. Venous ulcers are expensive to treat, have substantial economic effects in terms of days of work lost, and adversely impact the patient's quality of life. Relying on evidence allows for a rationale of clinical decision making. The objectives of venous ulcer management include the healing of the ulcer, prevention of recurrence, and improvement of edema. Compression is the cornerstone of venous ulcer therapy. Adjunctive modalities such as surgery, growth factors, grafting, biologic skin substitutes, dressings, and oral medication have differing levels of evidence supporting their use, and may also facilitate the healing process.

UR - http://www.scopus.com/inward/record.url?scp=73949094929&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73949094929&partnerID=8YFLogxK

M3 - Article

C2 - 18802885

AN - SCOPUS:73949094929

VL - 17

SP - 77

EP - 83

JO - Surgical technology international

JF - Surgical technology international

SN - 1090-3941

ER -